Amwell expands digital clinical programs through partnership with dariohealth

Boston--(business wire)--amwell® (nyse: amwl), a leader in digital healthcare enablement, today announced the expansion of its digital clinical programs to include a cardiometabolic program, enabling health plans and clinicians to seamlessly connect members living with common chronic diseases, such as diabetes and high blood pressure, to dario's highly personalized digital therapeutic solution on the amwell platform.
AMWL Ratings Summary
AMWL Quant Ranking